🌱 #BioRegionCatalonia accelerates its path to sustainability! 🌍 🏥 Did you know? Paradoxically, the life sciences and healthcare sector, which works to protect and improve people’s health, is also one of the main sources of pollution, impacting well-being with significant resource consumption, such as energy and water. 🔋 POWER USE Healthcare facilities are energy-intensive, operating 24/7 with power-hungry equipment. Here are some initiatives that are leading the way to energy efficiency: 🏥 Hospital de Viladecans: Pioneering the use of geothermal energy for heating and hot water. 🔄 PRBB (Barcelona Biomedical Research Park): Renovated its data center to boost energy efficiency. ❄ Bellvitge Biomedical Research Institute - IDIBELL: Increased temperatures in ULT freezers and upgraded 10 units, saving power and reducing emissions. ☀ Hospital de Barcelona and Hospital del Mar: Installed solar panels, with Hospital del Mar pioneering them on its new building! 💧 WATER USE Healthcare professionals use 10 times more water than office workers! These initiatives are making strides in water conservation: 💧 Fundació Salut Empordà: Implemented 30+ actions to reduce water usage over the past year. 🎮 Universitat de Barcelona: Launched a gamified initiative to encourage water conservation. 🔄 Consorci Hospitalari de Vic (CHV): Installed a system to reuse wastewater from hemodialysis units in ICU and heating systems. Discover more inspiring initiatives in the full article! 👇 https://lnkd.in/dM_njXKR
Biocat, BioRegion of Catalonia
Investigación biotecnológica
Barcelona, Catalonia 34.709 seguidores
Doing now what the BioRegion of Catalonia needs next
Sobre nosotros
Biocat is the institution that promotes the life sciences and healthcare ecosystem in Catalonia and works to maximize its economic and social impact. Biocat’s strategy focuses on positioning the BioRegion of Catalonia as one of the leading European hubs, offering researchers and professionals innovative capacity with programs to improve talent and entrepreneurship, accelerating technology transfer and business growth by supporting TTOs and startups, and helping attract investors and investment to the ecosystem. Created in 2006 by the Government of Catalonia and the Barcelona City Council, Biocat also promotes far-reaching political strategies and projects aimed at contributing to Catalonia’s competitiveness.
- Sitio web
-
http://www.biocat.cat/en
Enlace externo para Biocat, BioRegion of Catalonia
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Barcelona, Catalonia
- Tipo
- Organización sin ánimo de lucro
- Fundación
- 2006
- Especialidades
- biotechnology, life sciences, pharmaceuticals, biomedicine, internationalisation, business competitiveness, regional development, cluster management, medtech, digital health, healthcare, innovation, entrepreneurship, biotech, techtransfer, market access y startups
Ubicaciones
-
Principal
Baldiri Reixach, 4-8, Torre I (PCB)
Barcelona, Catalonia 08028, ES
Empleados en Biocat, BioRegion of Catalonia
-
Silvia Labé
Marketing | Communications | Branding | Competitive Intelligence | Strategy. Working to position Catalonia's Life Sciences & Healthcare Innovation…
-
Monica Montero
Head of Business Intelligence at Biocat
-
Ingrid Tarragó
DIRECTORA DE MARCA Y PROMOCIÓN. Creando marcas coherentes y duraderas. Estratega y comunicadora. Apasionada y entusiasta.
-
Robert Fabregat Fuentes
CEO of Biocat
Actualizaciones
-
🔝 Barcelona es consolida com a seu de Biospain 2025 i 2027. Organitzat per AseBio - Asociación Española de Bioempresas en col·laboració amb Biocat, Generalitat de Catalunya i Ajuntament de Barcelona, aquest esdeveniment és un dels més importants del sector biotecnològic a Europa. La decisió de celebrar-lo novament a Barcelona reforça la ciutat com a epicentre del sector. La intenció és que Barcelona també sigui la seu de BIOSPAIN l’any 2029. 📆 La 12a edició se celebrarà del 7 al 9 d'octubre de 2025 a Fira Barcelona i preveu reunir més de 2.000 professionals i 1.000 entitats. 💬 Robert Fabregat Fuentes, DG de #Biocat: "És un orgull per a Biocat haver contribuït al fet que BIOSPAIN torni a triar Barcelona com a seu per a les seves edicions 2025 i 2027. Aquesta decisió reflecteix el reconeixement internacional del nostre ecosistema com un referent en el sector biotecnològic i biofarmacèutic" 🗨️ Miquel Sàmper Rodríguez, conseller d'Empresa i Treball de la Generalitat de Catalunya: "El sector biotec és clau per entendre Catalunya com un territori innovador. Comptem amb uns ecosistemes farmacèutic i tecnològic molt competitius internacionalment." 🗨️ Jordi Valls, tinent d'alcalde de l'Àrea d'Economia, Hisenda, Promoció Econòmica i Turisme de l'Ajuntament de Barcelona: “Barcelona és la capital científica i de la salut d'Espanya i del sud d'Europa. Per això estem encantats d'acollir les dues pròximes edicions de BIOSPAIN, perquè estem convençuts que trobaran el millor ecosistema per a continuar creixent i guanyant impacte internacional" 🗨Rocio Arroyo, presidenta de AseBio - Asociación Española de Bioempresas: "BIOSPAIN és la trobada de referència per a reunir el sector biotecnològic espanyol, i mostrar el seu creixement imparable i potencial transformador. Celebrar aquest congrés de nou a Barcelona ens permetrà consolidar la nostra projecció i impacte a escala internacional" 💡 L'anterior edició, celebrada també a Barcelona, va ser la més multitudinària, confirmant el lideratge de la #BioRegióCatalunya que compta amb 1.400 empreses i 91 institucions d'investigació. 🔗 Descobreix tots els detalls d’aquest esdeveniment de referència en biotecnologia 👇 https://lnkd.in/dZwrUgR7
-
🙋♀️ Join the #BCNHealthInnovationWeek 2025! 🚀 Startups, scaleups, industry experts, and consultants—register your activity and connect with a global audience eager to discover the latest health innovations crafted in Barcelona. 💡 From in-house roundtables and online webinars to product demos, facility tours, and training workshops, we’re excited to feature your contributions! ✍ Submit your activity today! https://lnkd.in/d7EesCwG Thank you to the 2025 ecosystem partners for making the Barcelona Health Innovation Week possible: ACCIÓ Alira Health Almirall Amgen España AstraZeneca Fundación Pasqual Maragall Barcelona Health Hub B. Braun Group Catalonia.Health (CataloniaBio & HealthTech) Hospital Clínic de Barcelona DeepLabs Grupo DKV ESTEVE Farmaindustria Fenin, Federación Española de Empresas de Tecnología Sanitaria Healthtech Innovations SL i2CAT IDNEO INNOVAMED Spain IOMED Johnson & Johnson Menarini España Partners In Health Pfizer Sanofi Hospital Sant Joan de Déu Barcelona Vall d'Hebron Barcelona Hospital Campus
-
🙌 Barcelona Deep Tech Summit is back in Barcelona! 📆 From November 5 to 7, join us within the Smart City Expo World Congress, a combined platform driving innovation in Deep Tech and urban development. ✅ This summit addresses four major global challenges, offering a range of conferences, panel discussions, workshops, and more. 🏥 One key focus is on advancements in health technology—transforming disease prevention, diagnosis, and treatment with an emphasis on universal healthcare access. 🔗 Don’t miss out! 👇 https://lnkd.in/dRb5nXNz
-
🚀 We're gearing up for the presentation of the #BioRegionReport 2025! This presentation will kick off the #BCNHealthInnovation Week. Over 700 professionals attended last year's edition. Are you going to miss it? 📅 When: 17/02/25 📍 Where: Auditori l'Illa 👉 Register now: https://lnkd.in/demWi7At 📝 The #BioRegionCatalonia Report, published by #Biocat since 2009, has become the most solid and wide-reaching analysis of the assets, achievements and trends in the life sciences and healthcare sector in Catalonia within an international framework. 🔎 As we prepare for the 2024 edition, let’s take a moment to reflect on some of the standout achievements from the #BioRegionReport 2023, which highlighted Catalonia as one of the most dynamic and competitive hubs for health innovation in Europe: ✔ Health startups and scaleups in Catalonia raised €220 million in 2023. ✔ Catalonia ranks among the top 10 globally for clinical trial participation, placing 5th in Europe and 8th worldwide. ✔ Catalonia saw €1.025 billion in foreign investment—a 110% increase from the previous year, with the new AstraZeneca hub playing a key role in this growth. This event is proudly supported by our sponsors and collaborators, who are key to making the #BioRegionReport possible: Alira Health AstraZeneca Johnson & Johnson Menarini España Roche Amgen España Almirall ESTEVE Pfizer Sanofi ACCIÓ Catalonia.Health (CataloniaBio & HealthTech) Farmaindustria Fenin, Federación Española de Empresas de Tecnología Sanitaria
-
🚀 Calling all companies, technology centers, and startups! 🟢 ACCIÓ’s Open Innovation Challenges are open! Connect with companies and public entities seeking innovative solutions and collaborate with top technology providers at exclusive business meetings. 🌍 If your innovation is ready to address real industry challenges, this program is the perfect stage to make an impact in the framework of international congresses held in Catalonia such as Mobile World Congress (#MWC25), Integrated Systems Europe (ISE), Smart City Expo World Congress, @Health Revolution Congress (Barcelona Health Hub) or ADVANCED FACTORIES. 🤝 How do Open Innovation Challenges work? ☑ Choose the event that best suits you. ☑ Enter the platform and register your solution. ☑ Check out and select the company challenges. ☑ Request an on-site or on-line meeting. ☑ If your solution is attractive, the company will agree to the meeting. 💡 Ready to join? Step into the future of innovation in Catalonia. Let’s make your disruptive solutions shine! https://lnkd.in/dhYTJnQ9
-
🎧 PODCAST: El Capital Risc Públic de Catalunya BioEmprendedores conversa amb Claudia Canals, directora general d'AVANÇSA, una empresa pública encarregada d’impulsar l'ecosistema empresarial de Catalunya. Mitjançant el finançament de projectes, el seu objectiu és fomentar la reactivació industrial i impulsar projectes innovadors d'alt valor afegit i diferencials, que contribueixin a la sostenibilitat i a l'ocupació de qualitat. Escolta'l! https://lnkd.in/dayZ_ZFn
-
🔝🔺Top 3 Smart Read & Tips: 📖 EIF VC Survey 2024: Market sentiment: The report highlights a challenging outlook for venture capital in 2024, with over 60% of fund managers pointing to difficulties in fundraising. The financing gap for scale-ups continues to widen, with increasing barriers to securing funding and attracting talent. 📖 Rethinking Healthcare Systems / European University Hospital Alliance (EUHA) Europe’s healthcare systems are facing significant challenges, including workforce shortages, rising care demands and costs, demographic shifts, and emerging threats such as climate change and new epidemics. A comprehensive transformation is needed, emphasizing integration, prevention, and innovation as fundamental pillars. 📖 Pharma needs to step out of its comfort zone with AI and digital health / Faces of Digital Health / Faces Of Digital Health Podcast "Patient odysseys," "pilotitis," and "vendor clutter" were prominent descriptors at the Digital Health and AI Innovation Summit in Boston (DHAI), summarizing the current state of AI and digital health in Pharma. Discover them 👇 https://lnkd.in/dgapMxH2
-
💡 Núria Martí Ras, directora d'Innovació i Desenvolupament de Negoci de #Biocat ha participat en el 34è Fòrum d'Inversió Healthcare Barcelona, un referent en l'ecosistema biomèdic català que vol apropar emprenedors i inversors del sector sanitari. AIMS-Medical SL, BrainFocus, CONUS, D-Sight S.L., Golden Gait Biotech, Health-Circuit, Loop Dx, Lumiris Spectral Solutions, Nema-Health i Robopedics han presentat els seus projectes a inversors.
-
🌟 This October has been transformative for the #BioRegionCatalonia! From major investments and new initiatives to groundbreaking collaborations, here are the top stories you need to know: 🔺 INBRAIN Neuroelectronics raises a $50M funding round 🔺 The new Hospital Clínic de Barcelona will begin operations in 2035 🔺 Hospital Sant Joan de Déu Barcelona and Hospital Clínic de Barcelona worked together to create a platform to produce advanced therapies. 🔺 Oryzon Genomics SA has its sights set on the Nasdaq after gaining approval for its borderline personality disorder therapy. 🔺 Galenicum expands into dermatology sector by acquiring four Ferrer brands. 🔺 We've discovered the names of the 11 members of the panel of experts to reform public healthcare. It will be led by Manel del Castillo Rey and will include big names such as Carmen Cabezas and Josep Tabernero MD, PhD. 🔺 ICF - Institut Català de Finances invests €3M in the CRB Inverbío SGEIC III, the first specialized in digital health. 🔺 New leaderships in key positions of the #BioRegionCatalonia: Josep M. Pomar Reynés, has been appointed director of Institut Català de la Salut, Manel Balcells returns as director of CIMTI and Fina Lladós Canela will take over as president of @farmaindustria 🔺 Discover how entities in the #BioRegionCatalonia are working to become more sustainable. 🔺 Registration is opened to attend #BioRegionReport presentation, that will take place during #BCNHealthInnovationWeek. We tell you about all of them on our monthly wrap up 👇 🔗 https://lnkd.in/dYdhV-Ei Would you prefer to receive this monthly content by e-mail, you can subscribe to the BioRegion Bites newsletter: 📲 https://lnkd.in/eg43Bxhh